These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

489 related articles for article (PubMed ID: 24464982)

  • 1. Cellular and metabolic alterations in the hippocampus caused by insulin signalling dysfunction and its association with cognitive impairment during aging and Alzheimer's disease: studies in animal models.
    Calvo-Ochoa E; Arias C
    Diabetes Metab Res Rev; 2015 Jan; 31(1):1-13. PubMed ID: 24464982
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Insulin resistance in the brain: an old-age or new-age problem?
    Williamson R; McNeilly A; Sutherland C
    Biochem Pharmacol; 2012 Sep; 84(6):737-45. PubMed ID: 22634336
    [TBL] [Abstract][Full Text] [Related]  

  • 3. (Pre)diabetes, brain aging, and cognition.
    S Roriz-Filho J; Sá-Roriz TM; Rosset I; Camozzato AL; Santos AC; Chaves ML; Moriguti JC; Roriz-Cruz M
    Biochim Biophys Acta; 2009 May; 1792(5):432-43. PubMed ID: 19135149
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cognitive decline in STZ-3V rats is largely due to dysfunctional insulin signalling through the dentate gyrus.
    Shingo AS; Kanabayashi T; Murase T; Kito S
    Behav Brain Res; 2012 Apr; 229(2):378-83. PubMed ID: 22289199
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hippocampal insulin resistance and cognitive dysfunction.
    Biessels GJ; Reagan LP
    Nat Rev Neurosci; 2015 Nov; 16(11):660-71. PubMed ID: 26462756
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lipoic acid improves neuronal insulin signalling and rescues cognitive function regulating VGlut1 expression in high-fat-fed rats: Implications for Alzheimer's disease.
    Rodriguez-Perdigon M; Solas M; Moreno-Aliaga MJ; Ramirez MJ
    Biochim Biophys Acta; 2016 Apr; 1862(4):511-517. PubMed ID: 26769360
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Alzheimer disease and cognitive impairment associated with diabetes mellitus type 2: associations and a hypothesis.
    Domínguez RO; Pagano MA; Marschoff ER; González SE; Repetto MG; Serra JA
    Neurologia; 2014; 29(9):567-72. PubMed ID: 24140159
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Insulin signalling in Alzheimer's disease and diabetes: from epidemiology to molecular links.
    Ribe EM; Lovestone S
    J Intern Med; 2016 Nov; 280(5):430-442. PubMed ID: 27739227
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inflammation, defective insulin signaling, and neuronal dysfunction in Alzheimer's disease.
    Ferreira ST; Clarke JR; Bomfim TR; De Felice FG
    Alzheimers Dement; 2014 Feb; 10(1 Suppl):S76-83. PubMed ID: 24529528
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Defective Insulin Signalling, Mediated by Inflammation, Connects Obesity to Alzheimer Disease; Relevant Pharmacological Therapies and Preventive Dietary Interventions.
    Rodriguez-Casado A; Toledano-Díaz A; Toledano A
    Curr Alzheimer Res; 2017; 14(8):894-911. PubMed ID: 28317485
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunoglobulin G Fc receptor deficiency prevents Alzheimer-like pathology and cognitive impairment in mice.
    Fernandez-Vizarra P; Lopez-Franco O; Mallavia B; Higuera-Matas A; Lopez-Parra V; Ortiz-Muñoz G; Ambrosio E; Egido J; Almeida OF; Gomez-Guerrero C
    Brain; 2012 Sep; 135(Pt 9):2826-37. PubMed ID: 22961553
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Liraglutide can reverse memory impairment, synaptic loss and reduce plaque load in aged APP/PS1 mice, a model of Alzheimer's disease.
    McClean PL; Hölscher C
    Neuropharmacology; 2014 Jan; 76 Pt A():57-67. PubMed ID: 23973293
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Diabetes as a risk factor for Alzheimer's disease: insulin signalling impairment in the brain as an alternative model of Alzheimer's disease.
    Hölscher C
    Biochem Soc Trans; 2011 Aug; 39(4):891-7. PubMed ID: 21787319
    [TBL] [Abstract][Full Text] [Related]  

  • 14. High-sugar diets, type 2 diabetes and Alzheimer's disease.
    Moreira PI
    Curr Opin Clin Nutr Metab Care; 2013 Jul; 16(4):440-5. PubMed ID: 23657152
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The impairment of insulin signaling in Alzheimer's disease.
    Candeias E; Duarte AI; Carvalho C; Correia SC; Cardoso S; Santos RX; Plácido AI; Perry G; Moreira PI
    IUBMB Life; 2012 Dec; 64(12):951-7. PubMed ID: 23129399
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Metabolic-cognitive syndrome: a cross-talk between metabolic syndrome and Alzheimer's disease.
    Frisardi V; Solfrizzi V; Seripa D; Capurso C; Santamato A; Sancarlo D; Vendemiale G; Pilotto A; Panza F
    Ageing Res Rev; 2010 Oct; 9(4):399-417. PubMed ID: 20444434
    [TBL] [Abstract][Full Text] [Related]  

  • 17. PI3-kinase/Akt/mTOR signaling: impaired on/off switches in aging, cognitive decline and Alzheimer's disease.
    O' Neill C
    Exp Gerontol; 2013 Jul; 48(7):647-53. PubMed ID: 23470275
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The therapeutic potential of metabolic hormones in the treatment of age-related cognitive decline and Alzheimer's disease.
    Grizzanti J; Lee HG; Camins A; Pallas M; Casadesus G
    Nutr Res; 2016 Dec; 36(12):1305-1315. PubMed ID: 27923524
    [TBL] [Abstract][Full Text] [Related]  

  • 19. When aging-onset diabetes is coming across with Alzheimer disease: comparable pathogenesis and therapy.
    Tang J; Pei Y; Zhou G
    Exp Gerontol; 2013 Aug; 48(8):744-50. PubMed ID: 23648584
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Insulin signaling, glucose metabolism and mitochondria: major players in Alzheimer's disease and diabetes interrelation.
    Correia SC; Santos RX; Carvalho C; Cardoso S; Candeias E; Santos MS; Oliveira CR; Moreira PI
    Brain Res; 2012 Mar; 1441():64-78. PubMed ID: 22290178
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 25.